Cancer and Alzheimer’s disease inverse relationship: an age-associated diverging derailment of shared pathways

SEER Cancer Statistics Review, 1975-2003

Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693

Cancer Statistics, 2007

Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439

The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation

Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,897

Otto Warburg's contributions to current concepts of cancer metabolism

Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427

hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase

Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,690

Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress

Tabas, I. A., & Ron, D. (2011) · Nature Cell Biology · doi:10.1038/ncb0311-184 · Cited by 2,655

Notch signalling: a simple pathway becomes complex

Bray, S. J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2009 · Cited by 2,620

Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors

Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379

A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain

De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J., et al. (1999) · Nature · doi:10.1038/19083 · Cited by 2,100

ER stress-induced cell death mechanisms

Sano, R., & Reed, J. C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.028 · Cited by 1,988

p53 mutant mice that display early ageing-associated phenotypes

Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 1×

Essential role of mouse telomerase in highly proliferative organs

Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270

The antioxidant function of the p53 tumor suppressor

Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,137

Energy metabolism in tumor cells

Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, Á., & Saavedra, E. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,121

Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.

Masters, C. L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R. N., & Beyreuther, K. T. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04000.x · Cited by 1,048

The impact of the unfolded protein response on human disease

Wang, S., & Kaufman, R. J. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201110131 · Cited by 992

A human peptidyl–prolyl isomerase essential for regulation of mitosis

Lu, K. P., Hanes, S. D., & Hunter, T. (1996) · Nature · doi:10.1038/380544a0 · Cited by 908

Notch signalling in solid tumours: a little bit of everything but not all the time

Ranganathan, P., Weaver, K. L., & Capobianco, A. J. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3035 · Cited by 841

Hydrogen peroxide as second messenger in lymphocyte activation

Reth, M. G. (2002) · Nature Immunology · doi:10.1038/ni1202-1129 · Cited by 793

Sequence-Specific and Phosphorylation-Dependent Proline Isomerization: A Potential Mitotic Regulatory Mechanism

Yaffe, M. B., Schutkowski, M., Shen, M., Zhou, X. Z., Stukenberg, P. T., Rahfeld, J., Xu, J., Kuang, J., Kirschner, M. W., Fischer, G. S., et al. (1997) · Science · doi:10.1126/science.278.5345.1957 · Cited by 770

THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS

Rowinsky, E. K. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.353 · Cited by 724

Function of WW Domains as Phosphoserine- or Phosphothreonine-Binding Modules

Lu, P., Zhou, X. Z., Shen, M., & Lu, K. P. (1999) · Science · doi:10.1126/science.283.5406.1325 · Cited by 688

Proteostasis impairment in protein-misfolding and -aggregation diseases

Hipp, M. S., Park, S.-H., & Hartl, F. U. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.05.003 · Cited by 683

The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease

Lu, K. P., & Zhou, X. Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2261 · Cited by 682

Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.

Sigal, A., & Rotter, V. (2000) · PubMed · Cited by 669

Mechanisms of tau-induced neurodegeneration

Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628

DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease

Yang, Y., Geldmacher, D., & Herrup, K. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 609

Centrosome composition and microtubule anchoring mechanisms

Bornens, M. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(01)00290-3 · Cited by 570

The Warburg effect then and now: From cancer to inflammatory diseases

Pålsson‐McDermott, E. M., & O'Neill, L. A. J. (2013) · BioEssays · doi:10.1002/bies.201300084 · Cited by 553

Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain

Busser, J., Geldmacher, D. S., & Herrup, K. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02801.1998 · Cited by 543

Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c‐Jun towards cyclin D1

Wulf, G. M., Ryo, A., Wulf, G. G., Lee, S. W., Niu, T., Petkova, V., & Lu, K. P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3459 · Cited by 529

Activation of the atf6, xbp1 and grp78 genes in human hepatocellular carcinoma: A possible involvement of the er stress pathway in hepatocarcinogenesis

Shuda, M., Kondoh, N., Imazeki, N., Tanaka, K., Okada, T., Mori, K., Hada, A., Arai, M., Wakatsuki, T., Matsubara, O., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00029-1 · Cited by 520

Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau

Mandelkow, E.-M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J. R., & Mandelkow, E. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81496-9 · Cited by 515

The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production

Pastorino, L., Sun, A., Lu, P.-J., Zhou, X. Z., Balastik, M., Finn, G., Wulf, G., Lim, J., Li, S.-H., Li, X., et al. (2006) · Nature · doi:10.1038/nature04543 · Cited by 487

Sirtuins, a promising target in slowing down the ageing process

Grabowska, W., Sikora, E., & Bielak-Zmijewska, A. (2017) · Biogerontology · doi:10.1007/s10522-017-9685-9 · Cited by 470

MiR-34, SIRT1, and p53: The feedback loop

Yamakuchi, M., & Lowenstein, C. J. (2009) · Cell Cycle · doi:10.4161/cc.8.5.7753 · Cited by 468

Genetic signatures of exceptional longevity in humans

Sebastiani, P., Solovieff, N., DeWan, A. T., Walsh, K. M., Puca, A., Hartley, S. W., Melista, E., Andersen, S., Dworkis, D. A., Wilk, J. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029848 · Cited by 464

Incidence and Risk of Dementia: The Rotterdam study

Ott, A., Breteler, M. M. B., Harskamp, F. V., Stijnen, T., & Hofman, A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009489 · Cited by 455 · cited 1×

Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain

Vincent, I. J., Jicha, G. A., Rosado, M., & Dickson, D. W. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03588.1997 · Cited by 446

Differential Expression of Oxidative Phosphorylation Genes in Patients With Alzheimer's Disease: Implications for Early Mitochondrial Dysfunction and Oxidative Damage

Mańczak, M., Park, B. S., Jung, Y., & Reddy, P. H. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:2:147 · Cited by 434

Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration

Liou, Y., Sun, A., Ryo, A., Zhou, X. Z., Yu, Z.-X., Huang, H.-K., Uchida, T., Bronson, R. T., Bing, G., Li, X., et al. (2003) · Nature · doi:10.1038/nature01832 · Cited by 432

Sirt1 modulates premature senescence-like phenotype in human endothelial cells

Ota, H., Akishita, M., Eto, M., Iijima, K., Kaneki, M., & Ouchi, Y. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.008 · Cited by 429

Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study

Driver, J. A., Beiser, A., Au, R., Kreger, B. E., Splansky, G. L., Kurth, T., Kiel, D. P., Lu, K. P., Seshadri, S., & Wolf, P. A. (2012) · BMJ · doi:10.1136/bmj.e1442 · Cited by 425

Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells

Domenech, J. M. D., Vidal, S. J., Rodríguez-Bravo, V., Castillo-Martín, M., Quinn, S. A., Barrueco, R. R., Bonal, D. M., Charytonowicz, E., Gladoun, N., de la Iglesia-Vicente, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.016 · Cited by 423

Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

McShea, A., Harris, P. L. R., Webster, K. R., Wahl, A. F., & Smith, M. A. (1997) · Europe PMC (PubMed Central) · Cited by 422

The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults

Zacchi, P., Gostissa, M., Uchida, T., Salvagno, C., Avolio, F., Volinia, S., Ronai, Z. A., Blandino, G., Schneider, C., & Sal, G. D. (2002) · Nature · doi:10.1038/nature01120 · Cited by 413

Two faces of p53: aging and tumor suppression

Rodier, F., Campisi, J., & Bhaumik, D. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm744 · Cited by 412

The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response

Zheng, H., You, H., Zhou, X. Z., Murray, S. A., Uchida, T., Wulf, G. M., Gu, L., Tang, X., Lu, K. P., & Xiao, Z. J. (2002) · Nature · doi:10.1038/nature01116 · Cited by 390

Mitotic mechanisms in Alzheimer's disease?

Vincent, I., Rosado, M., & Davies, P. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.3.413 · Cited by 386

Genetics of healthy aging and longevity

Brooks-Wilson, A. R. (2013) · Human Genetics · doi:10.1007/s00439-013-1342-z · Cited by 380

Prevalent Overexpression of Prolyl Isomerase Pin1 in Human Cancers

Bao, L., Kimzey, A. L., Sauter, G., Sowadski, J. M., Lu, K. P., & Wang, D.-G. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63731-5 · Cited by 378

Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease

Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377

In Vivo Mitochondrial p53 Translocation Triggers a Rapid First Wave of Cell Death in Response to DNA Damage That Can Precede p53 Target Gene Activation

Erster, S. H., Mihara, M., Kim, R. H., Petrenko, O., & Moll, U. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6728-6741.2004 · Cited by 372

Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes

Liou, Y.-C., Ryo, A., Huang, H.-K., Lu, P., Bronson, R. T., Fujimori, F., Uchida, T., Hunter, T. R., & Lu, K. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032404099 · Cited by 341

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

Feldman, H., Ferris, S. H., Winblad, B. G., Sfikas, N., Mancione, L., He, Y., Tekin, S., Burns, A. S., Cummings, J. L., del Ser, T., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70109-6 · Cited by 340

Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions

Fernandez, P. M., Tabbara, S. O., Jacobs, L. K., Manning, F. C. R., Tsangaris, T. N., Schwartz, A. M., Kennedy, K. A., & Patierno, S. R. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006332011207 · Cited by 338

Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins

Liou, Y., Zhou, X. Z., & Lu, K. P. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.07.001 · Cited by 333

Health Span Approximates Life Span Among Many Supercentenarians: Compression of Morbidity at the Approximate Limit of Life Span

Andersen, S. L., Sebastiani, P., Dworkis, D. A., Feldman, L., & Perls, T. T. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr223 · Cited by 331

p53, Oxidative Stress, and Aging

Liu, D., & Xu, Y. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3644 · Cited by 322

Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease

de la Monte, S. M., Sohn, Y. K., & Wands, J. R. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00131-7 · Cited by 307

Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming

Ong, A. L. C., & Ramasamy, T. S. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.02.004 · Cited by 305

Efficacy of donepezil in mild cognitive impairment

Salloway, S., Ferris, S. H., Kluger, A., Goldman, R. S., Griesing, T., Kumar, D., & Richardson, S. (2004) · Neurology · doi:10.1212/01.wnl.0000134664.80320.92 · Cited by 301

Alzheimer disease, the two-hit hypothesis: An update

Zhu, X., Lee, H., Perry, G. L., & Smith, M. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.014 · Cited by 299

Inverse occurrence of cancer and Alzheimer disease: A population-based incidence study

Musicco, M., Adorni, F., Di Santo, S., Prinelli, F., Pettenati, C., Caltagirone, C., Palmer, K., & Russo, A. (2013) · Neurology · doi:10.1212/wnl.0b013e31829c5ec1 · Cited by 295

Cancer linked to Alzheimer disease but not vascular dementia

Roe, C. M., Fitzpatrick, A. L., Xiong, C., Sieh, W., Kuller, L. H., Miller, J. P., Williams, M. M., Kopan, R., Behrens, M. I., & Morris, J. C. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c91873 · Cited by 288

Mutant p53: an oncogenic transcription factor

Strano, S., Dell’Orso, S., Agostino, S. D., Fontemaggi, G., Sacchi, A., & Blandino, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210296 · Cited by 272

Safety and efficacy of galantamine in subjects with mild cognitive impairment

Winblad, B. G., Gauthier, S. G., Scinto, L. F. M., Feldman, H., Wilcock, G. K., Truyen, L., Mayorga, A. J., Wang, D., Brashear, H. R., Nye, J. S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000303815.69777.26 · Cited by 269

Cholinesterase in embryonic development.

Drews, U. (1975) · PubMed · Cited by 263

Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease

Nakamura, K., Greenwood, A., Binder, L. I., Bigio, E. H., Denial, S., Nicholson, L. K., Zhou, X. Z., & Lu, K. P. (2012) · Cell · doi:10.1016/j.cell.2012.02.016 · Cited by 260

PIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells

Ryo, A., Liou, Y.-C., Wulf, G. M., Nakamura, M., Lee, S. W., & Lu, K. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5281-5295.2002 · Cited by 254

The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging

Dumble, M. L., Moore, L. M., Chambers, S. M., Geiger, H., Zant, G. E. V., Goodell, M. A., & Donehower, L. A. (2006) · Blood · doi:10.1182/blood-2006-03-010413 · Cited by 249

Mitotic signaling by β‐amyloid causes neuronal death

Copani, A., Condorelli, F., CARUSO, A., Vancheri, C., Sala, A., Stella, A. M. G., Canonico, P. L., Nicoletti, F., & Sortino, M. A. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2225 · Cited by 246

Parkinson’s disease and cancer risk: a systematic review and meta-analysis

Bajaj, A., Driver, J. A., & Schernhammer, E. S. (2010) · Cancer Causes & Control · doi:10.1007/s10552-009-9497-6 · Cited by 244

Phosphorylation-specific prolyl isomerization: is there an underlying theme?

Wulf, G. M., Finn, G., Suizu, F., & Lu, K. P. (2005) · Nature Cell Biology · doi:10.1038/ncb0505-435 · Cited by 240

Cancer metabolism in space and time: Beyond the Warburg effect

Danhier, P., Bański, P., Payen, V. L., Grasso, D., Ippolito, L., Sonveaux, P., & Porporato, P. E. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.001 · Cited by 230

The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration

Giovanni, S. D., Knights, C. D., Rao, M., Yakovlev, A. G., Beers, J., Catania, J., Avantaggiati, M. L., & Faden, A. I. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601292 · Cited by 229

Role of Pin1 in the Regulation of p53 Stability and p21 Transactivation, and Cell Cycle Checkpoints in Response to DNA Damage

Wulf, G. M., Liou, Y., Ryo, A., Lee, S. W., & Lu, K. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200538200 · Cited by 228

Alzheimer disease and cancer

Roe, C. M., Behrens, M. I., Xiong, C., Miller, J. P., & Morris, J. C. (2005) · Neurology · doi:10.1212/01.wnl.0000152889.94785.51 · Cited by 226

Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions

Nagy, Z., Esiri, M. M., & Smith, A. D. (1997) · Acta Neuropathologica · doi:10.1007/s004010050617 · Cited by 225

BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression

MacLachlan, T. K., Somasundaram, K., Sgagias, M. K., Shifman, Y., Muschel, R. J., Cowan, K. H., & El‐Deiry, W. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2777 · Cited by 211

Atypical cancer pattern in patients with Parkinson's disease

Olsen, J. H., Friis, S., Frederiksen, K., McLaughlin, J. K., Mellemkjær, L., & Møller, H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602279 · Cited by 210

Variation in the human TP53 gene affects old age survival and cancer mortality

van Heemst, D., Mooijaart, S. P., Beekman, M., Schreuder, J., de Craen, A. J. M., Brandt, B. W., Slagboom, P. E., & Westendorp, R. G. J. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.10.001 · Cited by 207

The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease

Inestrosa, N. C., & Toledo, E. M. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-9 · Cited by 207

Molecular Evidence for the Inverse Comorbidity between Central Nervous System Disorders and Cancers Detected by Transcriptomic Meta-analyses

Ibáñez, K., Boullosa, C., Tabarés‐Seisdedos, R., Baudot, A., & Valencia, A. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004173 · Cited by 205

Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies

Catalá-López, F., Suárez‐Pinilla, M., Suárez‐Pinilla, P., Valderas, J. M., Gómez-Beneyto, M., Martı́nez, S., Balanzá‐Martínez, V., Climent, J., Valencia, A., McGrath, J. J., et al. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000356498 · Cited by 203

Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis

Wulf, G. M., Garg, P., Liou, Y., Iglehart, D., & Lu, K. P. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600323 · Cited by 201

The Search for Longevity and Healthy Aging Genes: Insights From Epidemiological Studies and Samples of Long-Lived Individuals

Murabito, J. M., Yuan, R., & Lunetta, K. L. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls089 · Cited by 200

Down-regulation of Myeloid Cell Leukemia-1 through Inhibiting Erk/Pin 1 Pathway by Sorafenib Facilitates Chemosensitization in Breast Cancer

Ding, Q., Huo, L., Yang, J.-Y., Xia, W., Wei, Y., Liao, Y., Chang, C.-J., Yang, Y., Lai, C., Lee, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0579 · Cited by 199

Clinical Phenotype of Families with Longevity

Atzmon, G., Schechter, C. B., Greiner, W., Davidson, D. E., Rennert, G., & Barzilai, N. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52068.x · Cited by 197

Cholinesterase in Embronic Development

Drews, U. (1975) · Progress in Histochemistry and Cytochemistry · doi:10.1016/s0079-6336(75)80008-8 · Cited by 197

Epidemiology and Pathophysiology of Prostate Cancer in African-American Men

Powell, I. J. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.09.024 · Cited by 184

Death-Associated Protein Kinase 1 Phosphorylates Pin1 and Inhibits Its Prolyl Isomerase Activity and Cellular Function

Lee, T. H., Chen, C.-H., Suizu, F., Huang, P., Schiene-Fischer, C., Daum, S., Zhang, Y. J., Goate, A., Chen, R.-H., Zhou, X. Z., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.005 · Cited by 183

Cancer and ageing: convergent and divergent mechanisms

Serrano, M., & Blasco, M. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2242 · Cited by 182

Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease

Gasparini, L., Racchi, M., Binetti, G. G., Trabucchi, M., Solerte, S. B., Alkon, D. L., Etcheberrigaray, R., Gibson, G. E., Blass, J. P., Paoletti, R., et al. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.17 · Cited by 177

Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage.

Hung, A. Y., Koo, E. H., Haass, C., & Selkoe, D. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9439 · Cited by 175

The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer

Rustighi, A., Tiberi, L., Soldano, A., Napoli, M., Nuciforo, P. G., Rosato, A., Kaplan, F. M., Capobianco, A. J., Pece, S., Fiore, P. P. D., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1822 · Cited by 170

p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells

Hooper, C., Meimaridou, E., Tavassoli, M., Melino, G., Lovestone, S., & Killick, R. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.03.026 · Cited by 165

Redox signalling and transition metals in the control of the p53 pathway

Méplan, C., Richard, M., & Hainaut, P. L. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00297-x · Cited by 164

The paradox of the unfolded protein response in cancer.

Vandewynckel, Y., Laukens, D., Geerts, A. M., Bogaerts, E., Paridaens, A., Verhelst, X., Janssens, S., Heindryckx, F., & Vlierberghe, H. V. (2013) · PubMed · Cited by 164

The non‐apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon

Tedeschi, A., & Giovanni, S. D. (2009) · EMBO Reports · doi:10.1038/embor.2009.89 · Cited by 163

Prolyl‐isomerase Pin1 controls normal and cancer stem cells of the breast

Rustighi, A., Zannini, A., Tiberi, L., Sommaggio, R., Piazza, S., Sorrentino, G., Nuzzo, S., Tuscano, A., Eterno, V., Benvenuti, F., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302909 · Cited by 161

Telomerase, senescence and ageing

Shawi, M., & Autexier, C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.007 · Cited by 160

Epigenetics of dementia: understanding the disease as a transformation rather than a state

Maloney, B., & Lahiri, D. K. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00065-x · Cited by 159

Apoptosis and aging: increased resistance to apoptosis enhances the aging process

Salminen, A., Ojala, J., & Kaarniranta, K. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0597-y · Cited by 158

Prevalence and Risks of Dementia in the Japanese Population: RERF's Adult Health Study Hiroshima Subjects

Yamada, M., Sasaki, H., Mimori, Y., Kasagi, F., Sudoh, S., Ikeda, J., Hosoda, Y., Nakamura, S., & Kodama, K. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb04577.x · Cited by 158

Minnesota multiphasic personality inventory-rated depression and the incidence of breast cancer

Hahn, R. C., & Petitti, D. B. (1988) · Cancer · doi:10.1002/1097-0142(19880215)61:4 · Cited by 157

The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP

Mantovani, F., Tocco, F., Girardini, J. E., Smith, P., Gasco, M., Lü, X., Crook, T., & Sal, G. D. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1306 · Cited by 155

Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity

Beekman, M., Nederstigt, C., Suchiman, H. E. D., Kremer, D., van der Breggen, R., Lakenberg, N., Alemayehu, W. G., de Craen, A. J. M., Westendorp, R. G. J., Boomsma, D. I., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003540107 · Cited by 153

Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease

van Dyck, C. H., Nygaard, H. B., Chen, K., Donohue, M., Raman, R., Rissman, R. A., Brewer, J. B., Koeppe, R. A., Chow, T. W., Rafii, M. S., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2050 · Cited by 150

Role of Cell Cycle Re-Entry in Neurons: A Common Apoptotic Mechanism of Neuronal Cell Death

Folch, J., Junyent, F., Verdaguer, E., Auladell, C., Pizarro, J. G., Beas‐Zárate, C., Pallàs, M., & Camins, A. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9277-4 · Cited by 144

Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease

McShea, A., Wahl, A. F., & Smith, M. A. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0680 · Cited by 140

Aging without Dementia is Achievable: Current Evidence from Epidemiological Research

Qiu, C., & Fratiglioni, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171037 · Cited by 140

A p53-CBP/p300 transcription module is required for GAP-43 expression, axon outgrowth, and regeneration

Tedeschi, A., Nguyen, T. N., Puttagunta, R., Gaub, P., & Giovanni, S. D. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.175 · Cited by 139

Targeting the unfolded protein response in neurodegeneration: A new approach to therapy

Halliday, M., & Mallucci, G. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.034 · Cited by 125

Buffering Mechanisms in Aging: A Systems Approach Toward Uncovering the Genetic Component of Aging

Bergman, A., Atzmon, G., Ye, K. Q., MacCarthy, T., & Barzilai, N. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030170 · Cited by 117

Modulation of Gene Expression by Tumor-Derived p53 Mutants

Scian, M. J., Stagliano, K. E., Ellis, M. A., Hassan, S., Bowman, M., Miles, M. F., Deb, S. P., & Deb, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1568 · Cited by 117

Elevated levels of pro‐apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE,in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease

Cenini, G., Sultana, R., Memo, M., & Butterfield, D. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00163.x · Cited by 117

Cancer prevalence and mortality in centenarians: a systematic review

Pavlidis, N., Stanta, G., & Audisio, R. A. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.09.007 · Cited by 115

Association of cancer and Alzheimer's disease risk in a national cohort of veterans

Frain, L., Swanson, D., Cho, K., Gagnon, D., Lu, K. P., Betensky, R. A., & Driver, J. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.04.012 · Cited by 115

Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance

Lee, T. H., Tun-Kyi, A., Shi, R., Lim, J., Soohoo, C., Finn, G., Balaštík, M., Pastorino, L., Wulf, G. M., Zhou, X. Z., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1818 · Cited by 114

Evidence for the Direct Binding of Phosphorylated p53 to Sites of DNA Breaks In vivo

Rashid, S. T. A., Dellaire, G., Cuddihy, A. R., Jalali, F., Vaid, M., Coackley, C. L., Folkard, M., Xu, Y., Chen, B. P. C., Chen, D. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0729 · Cited by 107

Brain pathologies in extreme old age

Neltner, J. H., Abner, E. L., Jicha, G. A., Schmitt, F. A., Patel, E., Poon, L. W., Marla, G., Green, R. C., Davey, A., Johnson, M. A., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.009 · Cited by 106

Cancer of the Oldest Old: What we Have Learned from Autopsy Studies

Stanta, G., Campagner, L., Cavallieri, F., & Giarelli, L. (1997) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30182-4 · Cited by 106

Post‐phosphorylation prolyl isomerisation of gephyrin represents a mechanism to modulate glycine receptors function

Zita, M. M., Marchionni, I., Bottos, E., Righi, M., Sal, G. D., Cherubini, E., & Zacchi, P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601625 · Cited by 103

A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer’s Disease, Glioblastoma and Lung cancer

Sánchez-Valle, J., Tejero, H., Ibáñez, K., Portero, J. L., Krallinger, M., Al‐Shahrour, F., Tabarés‐Seisdedos, R., Baudot, A., & Valencia, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-04400-6 · Cited by 101

p53 in neurodegenerative diseases and brain cancers

Checler, F., & da Costa, C. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.009 · Cited by 99

Death-associated protein kinase 1 has a critical role in aberrant tau protein regulation and function

Kim, B. M., You, M.-H., Chen, C.-H., Lee, S., Hong, Y., Hong, Y., Kimchi, A., Zhou, X. Z., & Lee, T. H. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.216 · Cited by 98

Cell cycle-related protein expression in vascular dementia and Alzheimer's disease

Smith, M., Nagy, Z., & Esiri, M. M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00509-1 · Cited by 97

Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest

Guillouf, C., Graña, X., Selvakumaran, M., Luca, A. D., Giordano, A., Hoffman‐Liebermann, B., & Liebermann, D. A. (1995) · Blood · doi:10.1182/blood.v85.10.2691.bloodjournal85102691 · Cited by 95

Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease

Chen, C.-H., Li, W., Rukhsana Sultana, A., You, M., Kondo, A., Shahpasand, K., Kim, B. M., Luo, M.-L., Nechama, M., Lin, Y., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.027 · Cited by 95

p53 at the crossroads between cancer and neurodegeneration

Lanni, C., Racchi, M., Memo, M., Govoni, S., & Uberti, D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.034 · Cited by 95

Phosphorylated Tau: Toxic, Protective, or None of the Above

Castellani, R. J., Nunomura, A., Lee, H., Perry, G. L., & Smith, M. A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14404 · Cited by 94

Coamplification of human acetylcholinesterase and butyrylcholinesterase genes in blood cells: correlation with various leukemias and abnormal megakaryocytopoiesis.

Lapidot-Lifson, Y., Prody, C. A., Ginzberg, D., Meytes, D., Zakut, H. V., & Soreq, H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4715 · Cited by 94

The prolyl-isomerase Pin1 activates the mitochondrial death program of p53

Sorrentino, G., Mioni, M., Giorgi, C., Ruggeri, N., Pinton, P., Moll, U. M., Mantovani, F., & Sal, G. D. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.112 · Cited by 92

Endoplasmic reticulum quality control in cancer: Friend or foe

Kim, H., Bhattacharya, A., & Qi, L. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.003 · Cited by 89

An inverse-Warburg effect and the origin of Alzheimer’s disease

Demetrius, L., & Simon, D. K. (2012) · Biogerontology · doi:10.1007/s10522-012-9403-6 · Cited by 89

Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53

Salvioli, S., Capri, M., Bucci, L., Lanni, C., Racchi, M., Uberti, D. L., Memo, M., Mari, D., Govoni, S. M., & Franceschi, C. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0639-6 · Cited by 87

Prolyl Isomerase Pin1 Promotes Amyloid Precursor Protein (APP) Turnover by Inhibiting Glycogen Synthase Kinase-3β (GSK3β) Activity

Ma, S. L., Pastorino, L., Zhou, X. Z., & Lu, K. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c111.298596 · Cited by 86

Does Alzheimer’s Disease Protect against Cancers? A Nationwide Population-Based Study

Ou, S., Lee, Y.-J., Hu, Y., Liu, C., Chen, T., Fuh, J., & Wang, S. (2012) · Neuroepidemiology · doi:10.1159/000341411 · Cited by 86

Maintenance of retinal stem cells byAbcg2is regulated by notch signaling

Bhattacharya, S., Das, A. V., Mallya, K. B., & Ahmad, I. (2007) · Journal of Cell Science · doi:10.1242/jcs.008417 · Cited by 83

Pin1 allows for differential Tau dephosphorylation in neuronal cells

Hamdane, M., Dourlen, P., Bretteville, A., Sambo, A., Ferreira, S., Ando, K., Kerdraon, O., Bégard, S., Geay, L., Lippens, G. M., et al. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.03.006 · Cited by 82

Duplicating Dangerously

Doxsey, S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00654-8 · Cited by 82

SENP1 deSUMOylates and Regulates Pin1 Protein Activity and Cellular Function

Chen, C.-H., Chang, C., Lee, T. H., Luo, M., Huang, P., Liao, P.-H., Wei, S., Li, F., Chen, R., Zhou, X. Z., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4360 · Cited by 82

Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas.

Zakut, H. V., Ehrlich, G., Ayalon, A., Prody, C. A., Malinger, G., Seidman, S., Ginzberg, D., Kehlenbach, R. H., & Soreq, H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114791 · Cited by 81

Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin

Grison, A., Mantovani, F., Comel, A., Agostoni, E., Gustincich, S., Persichetti, F., & Sal, G. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106198108 · Cited by 80

In Vivo Synaptic Density Imaging with 11 C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer Disease

Toyonaga, T., Smith, L. M., Finnema, S. J., Gallezot, J.-D., Naganawa, M., Bini, J., Mulnix, T., Cai, Z., Ropchan, J., Huang, Y., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.223867 · Cited by 79

Apoptosis in Parkinson's disease: Is p53 the missing link between genetic and sporadic Parkinsonism?

da Costa, C. A., & Checler, F. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.10.020 · Cited by 75

Alzheimer disease and cancer risk: a meta-analysis

Shi, H., Tang, B., Liu, Y.-W., Wang, X., & Chen, G. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1773-5 · Cited by 74

A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer’s disease

Raschetti, R., Maggini, M., Sorrentino, G. C., Martini, N., Caffari, B., & Vanacore, N. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0946-1 · Cited by 74

The Peptidyl-Isomerase Pin1 Regulates p27kip1 Expression through Inhibition of Forkhead Box O Tumor Suppressors

Brenkman, A. B., de Keizer, P. L. J., van den Broek, N. J. F., van der Groep, P., van Diest, P. J., van der Horst, A., de Vries-Smits, A. M. M., & Burgering, B. M. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1059 · Cited by 73

Biological Hallmarks of Cancer in Alzheimer’s Disease

Nudelman, K. N. H., McDonald, B. C., Lahiri, D. K., & Saykin, A. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1591-5 · Cited by 73

Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function

Rangasamy, V., Mishra, R., Sondarva, G. V., Das, S., Lee, T. H., Bakowska, J. C., Tzivion, G., Malter, J. S., Rana, B., Lu, K. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200804109 · Cited by 72

Prolyl Isomerase Pin1 Regulates Neuronal Differentiation via β-Catenin

Nakamura, K., Kosugi, I., Lee, D. Y., Hafner, A. V., Sinclair, D. A., Ryo, A., & Lu, K. P. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05688-11 · Cited by 69

Neuropathology and cognitive performance in self-reported cognitively healthy centenarians

Ganz, A. B., Beker, N., Hulsman, M., Sikkes, S. A. M., NBB, Scheltens, P., Smit, A. B., Rozemüller, A. J. M., Hoozemans, J. J. M., & Holstege, H. H. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0558-5 · Cited by 69

A role for cholinesterases in tumorigenesis?

Soreq, H., Lapidot-Lifson, Y., & Zakut, H. V. (1991) · PubMed · Cited by 68

Competitive electrochemical immunosensor for the detection of unfolded p53 protein in blood as biomarker for Alzheimer’s disease

Amor-Gutiérrez, O., Costa‐Rama, E., Varas, N. A., Martínez-Rodríguez, C., Novelli, A., Fernández‐Sánchez, M. T., & Costa‐García, A. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.09.042 · Cited by 67

Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk

White, R. S., Lipton, R. B., Hall, C. B., & Steinerman, J. R. (2013) · Neurology · doi:10.1212/wnl.0b013e3182941990 · Cited by 66

β-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain

Buoso, E., Lanni, C., Schettini, G., Govoni, S. M., & Racchi, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.05.002 · Cited by 66

Cancer in the oldest old

Andersen, S. L., Terry, D. F., Wilcox, M., Babineau, T. J., Malek, K. S., & Perls, T. T. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.08.019 · Cited by 65

Characterization of activities and forms of cholinesterases in human primary brain tumors

Razon, N., Soreq, H., Roth, E., Bartal, A., & Silman, I. (1984) · Experimental Neurology · doi:10.1016/0014-4886(84)90215-2 · Cited by 64

Triclosan-Evoked Neurotoxicity Involves NMDAR Subunits with the Specific Role of GluN2A in Caspase-3-Dependent Apoptosis

Szychowski, K. A., Wnuk, A., Rzemieniec, J., Kajta, M., Leszczyńska, T., & Wójtowicz, A. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1083-z · Cited by 64

Redox Control and Interplay Between p53 Isoforms: Roles in the Regulation of Basal p53 Levels, Cell Fate, and Senescence

Hafsi, H., & Hainaut, P. L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3771 · Cited by 60

Amyloid precursor protein in human breast cancer: An androgen‐induced gene associated with cell proliferation

Takagi, K., Ito, S., Miyazaki, T., Miki, Y., Shibahara, Y., Ishida, T., Watanabe, M., Inoue, S., Sasano, H., & Suzuki, T. (2013) · Cancer Science · doi:10.1111/cas.12239 · Cited by 59

Aberrancies in signal transduction and cell cycle related events in Alzheimer’s disease

Arendt, T., Holzer, M., Gärtner, U., & Brückner, M. K. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_14 · Cited by 58

PIN1 Inhibits Apoptosis in Hepatocellular Carcinoma through Modulation of the Antiapoptotic Function of Survivin

Cheng, C.-W., Chow, A. K.-M., Pang, R. W. C., Fok, E., Kwong, Y., & Tse, E. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.034 · Cited by 57

Mortality cancer risk in parkinsonian patients: A population-based study

Vanacore, N., Alegiani, S. S., Raschetti, R., & Meco, G. (1999) · Neurology · doi:10.1212/wnl.52.2.395 · Cited by 55

Association of cancer history with Alzheimer's disease onset and structural brain changes

Nudelman, K. N. H., Risacher, S. L., West, J. D., McDonald, B. C., Gao, S., Saykin, A. J., & Initiative, A. D. N. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00423 · Cited by 54

Mortality cancer risk in parkinsonian patients: A population-based study

Riggs, J. E., Vanacore, N., Alegiani, S. S., Raschetti, R., & Meco, G. (1999) · Neurology · doi:10.1212/wnl.53.5.1158-a · Cited by 53

Conversion to dementia in mild cognitive impairment diagnosed with DSM ‐5 criteria and with Petersen's criteria

Marcos, G., Santabárbara, J., López‐Antón, R., De‐la‐Cámara, C., Gracia‐García, P., Lobo, E., Pírez, G., Menchón, J. M., Palomo, T., Stephan, B. C. M., et al. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12543 · Cited by 53

Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism

Racchi, M., & Govoni, S. M. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01380-2 · Cited by 52

Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer’s disease

Lanctôt, K. L., Herrmann, N., & Loulou, M. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0302 · Cited by 51

Tumor Diagnosis Preceding Alzheimer's Disease Onset: Is There a Link Between Cancer and Alzheimer's Disease?

Realmuto, S., Cinturino, A., Arnao, V., Mazzola, M. A., Cupidi, C., Aridon, P., Ragonese, P., Savettieri, G., & D’Amelio, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120184 · Cited by 51

Cancer incidence in old age

Miyaishi, O., Ando, F., Matsuzawa, K., Kanawa, R., & Isobe, K. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00136-6 · Cited by 51

The inverse association of cancer and Alzheimer's: a bioenergetic mechanism

Demetrius, L., & Simon, D. K. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0006 · Cited by 48

Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression

O’Farrell, T. J., Ghosh, P., Dobashi, N., Sasaki, C. Y., & Longo, D. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3639 · Cited by 48

Association of Cancer History with Alzheimer’s Disease Dementia and Neuropathology

Yarchoan, M. M., James, B. D., Shah, R. C., Arvanitakis, Z., Wilson, R. S., Schneider, J. A., Bennett, D. A., & Arnold, S. E. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160977 · Cited by 47

Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors.

Gnatt, A. L., Prody, C. A., Zamir, R., Lieman‐Hurwitz, J., Zakut, H. V., & Soreq, H. (1990) · PubMed · Cited by 44

Alzheimer's Disease-Related Loss of Pin1 Function Influences the Intracellular Localization and the Processing of AβPP

Pastorino, L., Ma, S. L., Balaštík, M., Huang, P., Pandya, D., Nicholson, L. K., & Lu, K. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111259 · Cited by 42

p53 Pro-Oxidant Activity in the Central Nervous System: Implication in Aging and Neurodegenerative Diseases

Chatoo, W., Abdouh, M., & Bernier, G. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3610 · Cited by 41

Inverse correlation between Alzheimer’s disease and cancer: implication for a strong impact of regenerative propensity on neurodegeneration?

Li, J., Liu, C., Hu, X., Cai, Y., Ma, C., Luo, X., & Yan, X. (2014) · BMC Neurology · doi:10.1186/s12883-014-0211-2 · Cited by 41

A double‐blind, placebo‐controlled trial of memantine in age‐associated memory impairment (memantine in AAMI)

Ferris, S. H., Schneider, L. S. S., Farmer, M. V., Kay, G. G., & Crook, T. H. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1711 · Cited by 37

Copper Alters the Conformation and Transcriptional Activity of the Tumor Suppressor Protein p53 in Human Hep G2 Cells

Tassabehji, N. M., VanLandingham, J. W., & Levenson, C. W. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523001002 · Cited by 37

Tau proteins expressions in advanced breast cancer and its significance in taxane-containing neoadjuvant chemotherapy

Li, Z., Xiong, Q., Tu, J., Gong, Y., Qiu, W., Zhang, H., Wei, W.-S., Hou, Y., & Cui, W.-Q. (2013) · Medical Oncology · doi:10.1007/s12032-013-0591-y · Cited by 34

Activation of sphingosine kinase mediates suppressive effect of interleukin‐6 on human multiple myeloma cell apoptosis

Li, Q., Wu, C.-T., Duan, H., Sun, H., Wang, H., Lu, Z., Zhang, Q., Liu, H., & Wang, L. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06711.x · Cited by 33

Alzheimer Disease and Cancer

Sherzai, A. Z., Parasram, M., Haider, J. M., & Sherzai, D. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000369 · Cited by 32

Glioblastoma and dementia may share a common cause

Lehrer, S. P. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.01.031 · Cited by 31

Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer’s Disease

Monacelli, F., Cea, M., Borghi, R., Odetti, P. R., & Nencioni, A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160840 · Cited by 31

Unfolded p53 in Blood as a Predictive Signature Signature of the Transition from Mild Cognitive Impairment to Alzheimer's Disease

Lanni, C., Racchi, M., Stanga, S., Mazzini, G., Ranzenigo, A., Polotti, R., Memo, M., Govoni, S. M., & Uberti, D. L. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1347 · Cited by 29

Faster cognitive decline in elders without dementia and decreased risk of cancer mortality

Benito‐León, J., Romero, J. P., Louis, E. D., & Bermejo‐Pareja, F. (2014) · Neurology · doi:10.1212/wnl.0000000000000350 · Cited by 28

Zyxin is a novel target for beta‐amyloid peptide: characterization of its role in Alzheimer's pathogenesis

Lanni, C., Necchi, D., Pinto, A., Buoso, E., Buizza, L., Memo, M., Uberti, D. L., Govoni, S. M., & Racchi, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12154 · Cited by 25

Association between chemotherapy and cognitive impairments in a large cohort of patients with colorectal cancer

Du, X. L., Cai, Y., & Symanski, E. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1882 · Cited by 24

Clinicopathological analysis on cancers of autopsy cases in a geriatric hospital

Imalda, K., Hasegawa, R., Kato, T., Futakuchi, M., Takahashi, S., Ogawa, K., Asamoto, M., Yamamoto, T., Suzuki, K., Inagaki, T., et al. (1997) · Pathology International · doi:10.1111/j.1440-1827.1997.tb04496.x · Cited by 24

Chapter 16: Promoter elements and alternative splicing in the human ACHE gene

Ben-Aziz, R., Sternfeld, M., & Soreq, H. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62392-4 · Cited by 23

Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders?

Farshbaf, M. J., & Ghaedi, K. (2016) · BioMetals · doi:10.1007/s10534-016-9981-x · Cited by 22

Electrochemical detection of different p53 conformations by using nanostructured surfaces

Tonello, S., Stradolini, F., Abate, G., Uberti, D. L., Serpelloni, M., Carrara, S., & Sardini, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-53994-6 · Cited by 21

Mild Cognitive Impairment and Dementia Show Contrasting Associations with Risk of Cancer

van der Willik, K. D., Ruiter, R., Wolters, F. J., Ikram, M. K., Stricker, B. H. C., Hauptmann, M., Compter, A., Schagen, S. B., & Ikram, M. A. (2018) · Neuroepidemiology · doi:10.1159/000488892 · Cited by 20

AβPP Intracellular C-Terminal Domain Function is Related to its Degradation Processes

Buoso, E., Biundo, F., Lanni, C., Schettini, G., Govoni, S. M., & Racchi, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111961 · Cited by 17

Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s disease

Herdy, J. R., Traxler, L., Agarwal, R. K., Karbacher, L., Schlachetzki, J. C. M., Boehnke, L., Zangwill, D., Galasko, D., Glass, C. K., Mertens, J., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.11.010 · Cited by 208

FNDC5/Irisin: Physiology and Pathophysiology

Waseem, R., Shamsi, A., Mohammad, T., Hassan, M. I., Kazim, S. N., Chaudhary, A. A., Rudayni, H. A., Al-Zharani, M., Ahmad, F., & Islam, A. (2022) · Molecules · doi:10.3390/molecules27031118 · Cited by 180

A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health

Liu, S., Liu, J., He, L., Liu, L., Cheng, B. H., Zhou, F., Cao, D., & He, Y. (2022) · Molecules · doi:10.3390/molecules27144400 · Cited by 160

Amyloid-beta and tau protein beyond Alzheimer’s disease

Abyadeh, M., Gupta, V., Paulo, J. A., Mahmoudabad, A. G., Shadfar, S., Mirshahvaladi, S., Gupta, V. B., Nguyen, C. T. O., Finkelstein, D. I., You, Y., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.386406 · Cited by 126

Upregulation of ribosome complexes at the blood-brain barrier in Alzheimer's disease patients

Suzuki, M., Tezuka, K., Handa, T., Sato, R., Takeuchi, H., Takao, M., Tano, M., & Uchida, Y. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221111602 · Cited by 82

Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease

Driver, J. A., Zhou, X. Z., & Lu, K. P. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.12.025 · Cited by 95

Pin1: A New Genetic Link between Alzheimers Disease, Cancer and Aging

Driver, J. A., & Lu, K. P. (2010) · Current Aging Science · doi:10.2174/1874609811003030158 · Cited by 92

A Common Biological Mechanism in Cancer and Alzheimers Disease?

Behrens, M. I., Lendon, C., & Roe, C. M. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486608 · Cited by 186

A common molecular and cellular pathway in developing Alzheimer and cancer

Ali, M., Wani, S. U. D., Dey, T., Sridhar, S. B., & QADRIE, Z. L. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101625 · Cited by 14

Alzheimer Disease and Cancer

Sherzai, A. Z., Parasram, M., Haider, J. M., & Sherzai, D. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000369 · Cited by 32